MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly ...

Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on.

Cemsidomide Data Presented at American Society of Hematology (ASH) Annual Meeting Support Best-in-Class Profile; Program Advancing to Next Phase ...

AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations.

MELBOURNE, Australia and INDIANAPOLIS, Jan. 14, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today advises that Dr. Christian Behrenbruch, Managing ...

This year’s J.P. Morgan Healthcare Conference is projected to facilitate several deals worth over $10 billion, driven by the efforts of participating companies, including Korean industry powerhouses, ...